Presentation
2 March 2022 Evaluating drug impact on human gut microbiome by SRS-FISH
Author Affiliations +
Abstract
The gut microbiome has a considerable impact on human health. Furthermore, it is very sensitive to the in vivo environment changes. Entacapone (ENT) is one important human-targeted drug for the treatment of Parkinson’s disease shown to largely impact the growth of individual organisms in the gut microbiome. To resolve ENT incorporation and impact on gut microbiome activity in situ, we employed stimulated Raman scattering - fluorescence in situ hybridization (SRS-FISH) along with ultrafast delay line tuning. The hyperspectral chemical images acquired with this method could better preserve and separate the chemical information, thus enabled high-throughput identity-specific single cell metabolism analysis and mapping of drug incorporation by individual microbiome cells.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Xiaowei Ge, Fátima C. Pereira, Haonan Lin, Michael Wagner, and Ji-xin Cheng "Evaluating drug impact on human gut microbiome by SRS-FISH", Proc. SPIE PC11973, Advanced Chemical Microscopy for Life Science and Translational Medicine 2022, PC1197318 (2 March 2022); https://doi.org/10.1117/12.2609993
Advertisement
Advertisement
KEYWORDS
Mode conditioning cables

Hyperspectral imaging

Image acquisition

In vivo imaging

Luminescence

Macromolecules

Organisms

Back to Top